Amoéba S.A. 0RAE.L Stock
0.39 EUR
{{ price }}
0.000000%
{{change_pct}}%
COUNTRY
United Kingdom
Exchange
LSE
Market Cap
24.99K EUR
LOW - HIGH [24H]
0.0000
-
0.0000 EUR
VOLUME [24H]
60 EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.44 EUR
Amoéba S.A. Price Chart
Amoéba S.A. 0RAE.L Financial and Trading Overview
| Amoéba S.A. stock price | 0.39 EUR |
| Previous Close | 0.57 EUR |
| Open | 0 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 0 - 0 EUR |
| 52 Week Range | 0 - 1.37 EUR |
| Volume | 11.4K EUR |
| Avg. Volume | 2.62K EUR |
| Market Cap | 37.2K EUR |
| Beta (5Y Monthly) | 0.285823 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.44 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0RAE.L Valuation Measures
| Enterprise Value | 23.3M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.2372882 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.359 |
Trading Information
Amoéba S.A. Stock Price History
| Beta (5Y Monthly) | 0.285823 |
| 52-Week Change | -43.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.37 EUR |
| 52 Week Low | 0 EUR |
| 50-Day Moving Average | 0.67 EUR |
| 200-Day Moving Average | 0.84 EUR |
0RAE.L Share Statistics
| Avg. Volume (3 month) | 2.62K EUR |
| Avg. Daily Volume (10-Days) | 2.25K EUR |
| Shares Outstanding | 6.01M |
| Float | 44.81M |
| Short Ratio | N/A |
| % Held by Insiders | 3.02% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -27.13% |
| Return on Equity (ttm) | -191.23% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -1110000 EUR |
| EBITDA | -5346699 EUR |
| Net Income Avi to Common (ttm) | -8022894 EUR |
| Diluted EPS (ttm) | -0.44 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.53M EUR |
| Total Cash Per Share (mrq) | 0.12 EUR |
| Total Debt (mrq) | 2.36M EUR |
| Total Debt/Equity (mrq) | 28.84 EUR |
| Current Ratio (mrq) | 1.712 |
| Book Value Per Share (mrq) | 0.177 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4429012 EUR |
| Levered Free Cash Flow (ttm) | -3895670 EUR |
Profile of Amoéba S.A.
| Country | United Kingdom |
| State | N/A |
| City | Chassieu |
| Address | 38 Avenue de FrEres Montgolfier |
| ZIP | 69680 |
| Phone | 33 4 26 69 16 00 |
| Website | https://amoeba-nature.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 22 |
Amoéba S.A. produces biological biocides for the elimination of bacterial risk in water and human wounds. The company also offers biocontrol products for plant protection. It also develops applications using the amoeba Willaertia magna C2c Maky formation for plant protection. Amoéba S.A. was founded in 2010 and is based in Chassieu, France.
Q&A For Amoéba S.A. Stock
What is a current 0RAE.L stock price?
Amoéba S.A. 0RAE.L stock price today per share is 0.39 EUR.
How to purchase Amoéba S.A. stock?
You can buy 0RAE.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Amoéba S.A.?
The stock symbol or ticker of Amoéba S.A. is 0RAE.L.
How many shares does Amoéba S.A. have in circulation?
The max supply of Amoéba S.A. shares is 64.91K.
What is Amoéba S.A. Price to Earnings Ratio (PE Ratio)?
Amoéba S.A. PE Ratio is now.
What was Amoéba S.A. earnings per share over the trailing 12 months (TTM)?
Amoéba S.A. EPS is -0.44 EUR over the trailing 12 months.